- Home
- AMRX vs IVT Comparison
AMRX vs IVT Comparison
Compare AMRX & IVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRX
- IVT
- Stock Information
- Founded
- AMRX 2002
- IVT 2005
- Country
- AMRX United States
- IVT United States
- Employees
- AMRX N/A
- IVT N/A
- Industry
- AMRX Biotechnology: Pharmaceutical Preparations
- IVT Real Estate Investment Trusts
- Sector
- AMRX Health Care
- IVT Real Estate
- Exchange
- AMRX Nasdaq
- IVT Nasdaq
- Market Cap
- AMRX 2.7B
- IVT 2.3B
- IPO Year
- AMRX N/A
- IVT N/A
- Fundamental
- Price
- AMRX $8.47
- IVT $30.16
- Analyst Decision
- AMRX Strong Buy
- IVT Buy
- Analyst Count
- AMRX 5
- IVT 3
- Target Price
- AMRX $10.00
- IVT $31.33
- AVG Volume (30 Days)
- AMRX 1.1M
- IVT 412.8K
- Earning Date
- AMRX 11-08-2024
- IVT 10-29-2024
- Dividend Yield
- AMRX N/A
- IVT 3.00%
- EPS Growth
- AMRX N/A
- IVT 189.28
- EPS
- AMRX N/A
- IVT 0.10
- Revenue
- AMRX $2,680,420,000.00
- IVT $294,559,000.00
- Revenue This Year
- AMRX $17.56
- IVT N/A
- Revenue Next Year
- AMRX $3.23
- IVT $12.37
- P/E Ratio
- AMRX N/A
- IVT $344.68
- Revenue Growth
- AMRX 12.32
- IVT 13.58
- 52 Week Low
- AMRX $4.16
- IVT $23.53
- 52 Week High
- AMRX $9.48
- IVT $31.37
- Technical
- Relative Strength Index (RSI)
- AMRX 45.78
- IVT 53.69
- Support Level
- AMRX $7.52
- IVT $30.08
- Resistance Level
- AMRX $9.48
- IVT $31.37
- Average True Range (ATR)
- AMRX 0.35
- IVT 0.66
- MACD
- AMRX 0.02
- IVT -0.00
- Stochastic Oscillator
- AMRX 48.59
- IVT 63.73
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
About IVT InvenTrust Properties Corp.
InvenTrust Properties Corp is the United States of America based company qualified as a REIT (Real Estate Investment Trust). It is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The company's wholly-owned and managed retail properties include grocery-anchored community and neighborhood centers and power centers, including those classified as necessity-based. InvenTrust operates through a single segment i.e. multi-tenant retail.